杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/06/23 | 2,570 | 2,571 | 2,535 | 2,566 | +11 | +0.4% | 122,900 |
2015/06/22 | 2,509 | 2,560 | 2,509 | 2,555 | +39 | +1.6% | 118,300 |
2015/06/19 | 2,537 | 2,543 | 2,501 | 2,516 | +16 | +0.6% | 349,400 |
2015/06/18 | 2,504 | 2,519 | 2,486 | 2,500 | -15 | -0.6% | 170,200 |
2015/06/17 | 2,532 | 2,542 | 2,511 | 2,515 | -20 | -0.8% | 189,800 |
2015/06/16 | 2,555 | 2,579 | 2,525 | 2,535 | -24 | -0.9% | 158,100 |
2015/06/15 | 2,560 | 2,577 | 2,541 | 2,559 | -14 | -0.5% | 124,800 |
2015/06/12 | 2,558 | 2,590 | 2,557 | 2,573 | +20 | +0.8% | 311,800 |
2015/06/11 | 2,538 | 2,569 | 2,518 | 2,553 | +32 | +1.3% | 214,100 |
2015/06/10 | 2,535 | 2,558 | 2,509 | 2,521 | -14 | -0.6% | 196,100 |
2015/06/09 | 2,543 | 2,569 | 2,533 | 2,535 | -20 | -0.8% | 141,500 |
2015/06/08 | 2,589 | 2,589 | 2,546 | 2,555 | -19 | -0.7% | 156,600 |
2015/06/05 | 2,561 | 2,607 | 2,551 | 2,574 | -6 | -0.2% | 196,200 |
2015/06/04 | 2,594 | 2,600 | 2,555 | 2,580 | -32 | -1.2% | 281,100 |
2015/06/03 | 2,620 | 2,625 | 2,588 | 2,612 | -8 | -0.3% | 173,100 |
2015/06/02 | 2,615 | 2,646 | 2,602 | 2,620 | ±0 | ±0% | 153,700 |
2015/06/01 | 2,610 | 2,630 | 2,582 | 2,620 | +10 | +0.4% | 174,800 |
2015/05/29 | 2,655 | 2,677 | 2,606 | 2,610 | -57 | -2.1% | 283,000 |
2015/05/28 | 2,669 | 2,691 | 2,657 | 2,667 | +16 | +0.6% | 140,600 |
2015/05/27 | 2,665 | 2,686 | 2,643 | 2,651 | +3 | +0.1% | 162,100 |
2015/05/26 | 2,685 | 2,704 | 2,640 | 2,648 | -38 | -1.4% | 104,600 |
2015/05/25 | 2,674 | 2,713 | 2,670 | 2,686 | +4 | +0.1% | 106,300 |
2015/05/22 | 2,690 | 2,760 | 2,656 | 2,682 | -8 | -0.3% | 289,300 |
2015/05/21 | 2,705 | 2,728 | 2,675 | 2,690 | -18 | -0.7% | 165,500 |
2015/05/20 | 2,716 | 2,732 | 2,683 | 2,708 | -8 | -0.3% | 196,400 |
2015/05/19 | 2,672 | 2,722 | 2,661 | 2,716 | +35 | +1.3% | 187,900 |
2015/05/18 | 2,654 | 2,698 | 2,642 | 2,681 | +27 | +1% | 213,600 |
2015/05/15 | 2,650 | 2,662 | 2,625 | 2,654 | -3 | -0.1% | 268,200 |
2015/05/14 | 2,698 | 2,726 | 2,628 | 2,657 | -77 | -2.8% | 262,800 |
2015/05/13 | 2,763 | 2,784 | 2,681 | 2,734 | -52 | -1.9% | 209,600 |
2015/05/12 | 2,803 | 2,826 | 2,760 | 2,786 | -29 | -1% | 163,400 |
2015/05/11 | 2,829 | 2,873 | 2,813 | 2,815 | +36 | +1.3% | 157,500 |
2015/05/08 | 2,770 | 2,790 | 2,751 | 2,779 | -1 | ±0% | 130,100 |
2015/05/07 | 2,780 | 2,842 | 2,759 | 2,780 | +8 | +0.3% | 172,800 |
2015/05/01 | 2,731 | 2,793 | 2,731 | 2,772 | +16 | +0.6% | 135,400 |
2015/04/30 | 2,768 | 2,789 | 2,741 | 2,756 | -65 | -2.3% | 159,500 |
2015/04/28 | 2,851 | 2,859 | 2,813 | 2,821 | -8 | -0.3% | 128,300 |
2015/04/27 | 2,817 | 2,841 | 2,789 | 2,829 | +24 | +0.9% | 77,400 |
2015/04/24 | 2,802 | 2,815 | 2,773 | 2,805 | -18 | -0.6% | 155,900 |
2015/04/23 | 2,872 | 2,872 | 2,817 | 2,823 | -30 | -1.1% | 145,400 |
2015/04/22 | 2,852 | 2,860 | 2,824 | 2,853 | +16 | +0.6% | 140,600 |
2015/04/21 | 2,795 | 2,840 | 2,795 | 2,837 | +61 | +2.2% | 126,400 |
2015/04/20 | 2,777 | 2,829 | 2,761 | 2,776 | -44 | -1.6% | 223,400 |
2015/04/17 | 2,874 | 2,884 | 2,818 | 2,820 | -36 | -1.3% | 247,700 |
2015/04/16 | 2,830 | 2,860 | 2,807 | 2,856 | -1 | ±0% | 177,800 |
2015/04/15 | 2,840 | 2,881 | 2,840 | 2,857 | -12 | -0.4% | 188,600 |
2015/04/14 | 2,857 | 2,879 | 2,844 | 2,869 | +1 | ±0% | 162,200 |
2015/04/13 | 2,900 | 2,900 | 2,838 | 2,868 | -55 | -1.9% | 212,300 |
2015/04/10 | 2,966 | 2,977 | 2,887 | 2,923 | -43 | -1.4% | 294,500 |
2015/04/09 | 2,933 | 2,971 | 2,918 | 2,966 | +54 | +1.9% | 263,300 |
2401~
2450
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,200円 | +3.2% | +4.5% | 3.53% | 16.91倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 223,600円 | +21.7% | +999.9% | 0.00% | 9.31倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 305,000円 | +3.0% | +27.5% | 2.62% | 19.31倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 223,000円 | +0.4% | -8.4% | 2.38% | 28.62倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,300円 | +22.8% | - | 0.00% | 69.69倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム